Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

被引：0
|
作者：
Mansour Tobaiqy
Hajer Elkout
机构：
[1] University of Jeddah,Department of Pharmacology, College of Medicine
[2] University of Tripoli,Department of Family and Community Medicine, Medical Faculty
来源：
International Journal of Clinical Pharmacy | 2024年 / 46卷
关键词：
Liraglutide; Obesity; Psychiatric adverse events; Semaglutide; Suicide; Tirzepatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：488 / 495
页数：7
相关论文
共 50 条
  • [31] First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
    Kenneth L. McCall
    Bennett J. Doughty
    Brian J. Piper
    Heeral Naik
    Seraphine Bange
    Emily E. Leppien
    International Journal of Clinical Pharmacy, 2024, 46 : 515 - 521
  • [32] Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea
    Kang, Min-Gyu
    Sohn, Kyung-Hee
    Kang, Dong-Yoon
    Park, Han-Ki
    Yang, Min-Suk
    Lee, Ju-Yeun
    Kang, Hye-Ryun
    YONSEI MEDICAL JOURNAL, 2019, 60 (02) : 208 - 215
  • [33] Immune checkpoint inhibitors and potential risk of thromboembolic events: Analysis of the WHO global database of individual case safety reports
    Alghamdi, Eman A.
    Aljohani, Hadir
    Alghamdi, Waad
    Alharbi, Fawaz
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (08) : 1193 - 1199
  • [34] Psychiatric adverse events during aripiprazole associated to other antipsychotics: a retrospective study of cases reported within the French PharmacoVigilance database
    Kheloufi, F.
    Lepelley, M.
    Montastruc, F.
    Daveluy, A.
    Rouby, F.
    Drici, M. D.
    Mallaret, M.
    Micallef, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 72 - 73
  • [35] Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
    Abril Verden
    Mo Dimbil
    Robert Kyle
    Brian Overstreet
    Keith B. Hoffman
    Drug Safety, 2018, 41 : 357 - 361
  • [36] Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
    Verden, Abril
    Dimbil, Mo
    Kyle, Robert
    Overstreet, Brian
    Hoffman, Keith B.
    DRUG SAFETY, 2018, 41 (04) : 357 - 361
  • [37] Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports
    Goldman, Adam
    Bomze, David
    Dankner, Rachel
    Hod, Hanoch
    Meirson, Tomer
    Boursi, Ben
    Maor, Elad
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1432 - 1442
  • [38] Major Adverse Cardiovascular Events Related to Jak Inhibitors: A Disproportionality Analysis Using WHO Global Individual Case Safety Database
    Di Napoli, Raffaella
    Richez, Christophe
    Scavone, Cristina
    Singier, Allison
    Demorgues, Maxime
    Mascolo, Annamaria
    Capuano, Annalisa
    Salvo, Francesco
    DRUG SAFETY, 2024, 47 (12) : 1395 - 1395
  • [39] Alopecia in Association with Lamotrigine Use An Analysis of Individual Case Safety Reports in a Global Database
    Tengstrand, Maria
    Star, Kristina
    van Puijenbroek, Eugene P.
    Hill, Richard
    DRUG SAFETY, 2010, 33 (08) : 653 - 658
  • [40] Alopecia in Association with Lamotrigine UseAn Analysis of Individual Case Safety Reports in a Global Database
    Maria Tengstrand
    Kristina Star
    Eugène P. van Puijenbroek
    Richard Hill
    Drug Safety, 2010, 33 : 653 - 658
12345